๐Ÿ”Ž

Mutation Explorer

Select the mutations found in your test report. We'll explore what each one means for your diagnosis, risk category, and treatment options โ€” using the latest classification guidelines.

WHO 2022ELN 2022ICC 2022
๐Ÿ“„ How to read your pathology reportโ–ผ

When you review your Next-Generation Sequencing (NGS) or molecular pathology report, look for a section titled "Pathogenic Variants", "Mutations Detected", or "Genomic Findings".

Mutations are usually listed by the Gene Name (like NPM1 or TP53) followed by the specific variant code (like p.Trp288fs).

For this tool, you only need to select the Gene Name. Some genes have important specific sub-types (like FLT3-ITD vs FLT3-TKD) โ€” check your report closely for these distinctions.

โ„น๏ธ

Tip: Ignore sections labeled "Variants of Unknown Significance (VUS)" or "Benign / Likely Benign" as they typically don't influence diagnosis or treatment decisions.

Select Your Mutations

Tip: check your pathology or genomics report for gene names.

๐Ÿ”€ Structural Rearrangement / Fusion

๐Ÿ“ก Signal Transducer

๐Ÿงฒ Epigenetic Regulator

๐Ÿ” Transcription Factor

๐Ÿ›ก๏ธ Tumor Suppressor / DNA Checkpoint

โš™๏ธ Nucleolar Protein

โœ‚๏ธ Spliceosome

๐Ÿ”— Cohesin Complex

โš•๏ธ Medical Disclaimer: This tool is for educational purposes only. Classification and risk information is based on population-level studies. Always discuss your specific situation with your hematologist or oncologist.

๐Ÿ”’ Privacy Note: LeukemiaLens is not a HIPAA-certified entity. By selecting your mutations and creating a profile, you willingly share this health-related data to enable the tool's core functionality. We apply strict application-level encryption to this profile, but please ensure you do not share personally identifiable information.